OPTIMIZING CALCINEURIN INHIBITOR EXPOSURE IN KIDNEY TRANSPLANT RECIPIENTS EARLY AFTER TRANSPLANTATION

被引：0
|
作者：
Press, R. R. [1 ]
Ploeger, B. A. [2 ]
den Hartigh, J. [1 ]
van der Straaten, T. [1 ]
van Pelt, H. [1 ]
Danhof, M. [2 ]
de Fijter, H. [1 ]
Guchelaar, H. [1 ]
机构：
[1] Leiden Univ, Med Ctr, Leiden, Netherlands
[2] LACDR, LAPP, Leiden, Netherlands
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2009年 / 85卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S38 / S38
页数：1
相关论文
共 50 条
  • [1] Unexpected Early Calcineurin Inhibitor Nephrotoxicity in Pediatric Kidney Transplant Recipients.
    Yanik, M.
    Mannon, R.
    Seifert, M.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 750 - 750
  • [2] Calcineurin inhibitor withdrawal or tapering for kidney transplant recipients
    Karpe, Krishna M.
    Talaulikar, Girish S.
    Walters, Giles D.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (07):
  • [3] Early calcineurin-inhibitor to belatacept conversion in steroid-free kidney transplant recipients
    Tawhari, Ibrahim
    Hallak, Patrick
    Bin, Sofia
    Yamani, Fatmah
    Safar-Boueri, Maria
    Irshad, Aazib
    Leventhal, Joseph
    Ansari, Mohammed Javeed
    Cravedi, Paolo
    Gallon, Lorenzo
    [J]. FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [4] Impact of Calcineurin Inhibitor Use After Graft Failure on Sensitization in Repeat Kidney Transplant Recipients
    Saunders, K.
    Bova, S.
    Demehin, M.
    Haririan, A.
    Kukuruga, D.
    Niederhaus, S.
    Sparkes, T.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S843 - S843
  • [5] Factors affecting variability of sirolimus exposure in kidney transplant recipients on calcineurin inhibitor-free regimen
    Cattaneo, Dario
    Baldelli, Sara
    Cortinovis, Monica
    Perico, Norberto
    Gotti, Eliana
    Remuzzi, Giuseppe
    [J]. THERAPEUTIC DRUG MONITORING, 2007, 29 (04) : 475 - 475
  • [6] Everolimus exposure in cardiac transplant recipients is influenced by concomitant calcineurin inhibitor
    Brandhorst, Gunnar
    Tenderich, Gero
    Zittermann, Armin
    Oezpeker, Cenk
    Koerfer, Reiner
    Oellerich, Michael
    Armstrong, Victor William
    [J]. THERAPEUTIC DRUG MONITORING, 2008, 30 (01) : 113 - 116
  • [7] CONVERSION OF STABLE ABO-INCOMPATIBLE KIDNEY TRANSPLANT RECIPIENTS FROM MYCOPHENOLATE MOFETIL WITH STANDARD EXPOSURE CALCINEURIN INHIBITOR TO EVEROLIMUS WITH VERY LOW EXPOSURE CALCINEURIN INHIBITOR
    Uchida, Junji
    Machida, Yuichi
    Kabei, Kazuya
    Iwai, Tomoaki
    Kuwabara, Nobuyuki
    Naganuma, Toshihide
    Kumada, Norihiko
    Nakatani, Tatsuya
    [J]. TRANSPLANT INTERNATIONAL, 2013, 26 : 248 - 248
  • [8] Conversion from Calcineurin Inhibitor to Sirolimus in Kidney Transplantation Recipients with Malignancy
    Yoon, J.
    Kang, S.
    Kim, S.
    Baeck, C.
    Kim, H.
    Park, S. -K.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 744 - 744
  • [9] Reducing exposure to calcineurin inhibitors after kidney transplantation
    Padiyar, Aparna
    Hricik, Donald E.
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2008, 51 (06) : 882 - 884
  • [10] HYPERGLYCEMIA AFTER TRANSPLANTATION IN CALCINEURIN INHIBITOR TREATED INDIAN RENAL TRANSPLANT RECIPIENTS: INCIDENCE AND RISK FACTORS
    Sakhuja, Vinay
    Jabbar, Z.
    Kohli, H. S.
    Jha, V.
    Gupta, K. L.
    [J]. TRANSPLANT INTERNATIONAL, 2009, 22 : 170 - 170
12345